CLINICAL_TRIALS
trial_result
· 2016-09-15
Clinical Trial Update: Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes [Phase 2]
Summary
Phase 2 pediatric dose-finding study of linagliptin for type 2 diabetes completed, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2016-09-15